Most shocking to CARD workers was the termination of lead researcher Kendall Van Keuren-Jensen, who was announced internally ...

A hidden phase of Alzheimer’s appears decades before symptoms, offering a chance for early detection and treatment.

A 75-year-old man with a genetic predisposition for Alzheimer’s has yet to show signs of the disease. Could this offer ...

A man who should have developed early-onset Alzheimer's disease due to a genetic mutation is still symptom-free in his 70s.

A comprehensive national study examining dementia patient outcomes for Medicare Advantage beneficiaries with Alzheimer's disease and related dementias (ADRD) uncovered key insights into healthcare ...

A medical research center named after former U.S. Sen. Roy Blunt of Missouri is facing drastic workforce reductions as part ...

Alzheimer's disease is at the center of a revolutionary theory in neuroscience, where the mysteries of the human brain ...

Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time. Those medications, however, are not without their risks and side effects.

Feb. 11, 2025 — A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way ...

If you’re looking for a poster child for something this administration is doing that has no apparent support from anyone, I think you’ve got your winner.

Iowa native is the third member of his family to be diagnosed with Alzheimer's. Now, his community is rallying around him.

Alzheimer's disease (AD), the most common form of dementia, continues to remain one of modern medicine's greatest challenges.